UPLOAD Filing
Jazz Pharmaceuticals plc
Date: Aug. 8, 2025 · CIK: 0001232524 · Accession: 0000000000-25-008357
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-33500
Letter
Re: Jazz Pharmaceuticals plc Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-33500 Dear Philip Johnson:
August 8, 2025
Philip Johnson Executive Vice President and Chief Financial Officer Jazz Pharmaceuticals plc Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4, Ireland D04 E5W7
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 8, 2025 Philip Johnson Executive Vice President and Chief Financial Officer Jazz Pharmaceuticals plc Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4, Ireland D04 E5W7 Re: Jazz Pharmaceuticals plc Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-33500 Dear Philip Johnson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>